THE PROCTER AND GAMBLE COMPANY lobbying for THE PROCTER AND GAMBLE COMPANY

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$818,900.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 2269
To provide for a limitation on availability of funds for US Department of Agriculture, Watershed and Flood Prevention O…
S 1092
WIPPES Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 1219
Oral Health Products Inclusion Act

Lobbying activity 8

Pharmacy

-Issues related to FDA review of active ingredients in over-the-counter products

Health Issues

-Issues related to Generally Recognized as Safe (GRAS) and Additive Ingredients Regulation (no bill) -Issues related to New Approach Methodologies (NAMs) non-animal technologies used to evaluate drug safety and efficacy

Trade (domestic/foreign)

-Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) -Section 232 Pharmaceuticals Trade Investigation -Section 232 Semiconductors Trade Investigation -Section 232 Softwood Lumber Trade Investigation -Section 232 Medical Devices/PPE Trade Investigation -IEEPA Reciprocal Tariffs -Section 232 Industrial Machinery Trade Investigation -Section 122 Balance of Payment Tariffs -Section 232 Steel/Aluminum Trade Investigation -Section 301 Excess Capacity/Forced Labor Trade Investigation -Issues related to counterfeit products/illicit trade

Consumer Issues/Safety/Products

-Issues Related to Product Safety and Quality Assurance (No Bill) -FDA Menstrual Products Guidance

Chemicals/Chemical Industry

-Issues related to updating the Toxic Substances Control Act (No Bill) -Implementation of Cybersecurity Reporting Law

Environment/Superfund

-Issues related to sustainability -H.R.7502-Pro Recycled Materials Attribution Act (RMAA) -H.R. 2269/S. 1092 - Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

Taxation/Internal Revenue Code

-OECD Digital Tax Project (Global Minimum Tax Implementation) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions) -Ongoing Negotiations of US Bilateral Tax Treaties -H.R. 1219 - Oral Health Products Inclusion Act

Foreign Relations

-Mexico Foreign Direct Investment Policies